Enhancement of the HIV-1-Specific Immune Response Induced by an mRNA Vaccine through Boosting with a Poxvirus MVA Vector Expressing the Same Antigen

Development of a vaccine against HIV remains a major target goal in the field. The recent success of mRNA vaccines against the coronavirus SARS-CoV-2 is pointing out a new era of vaccine designs against pathogens. Here, we have generated two types of mRNA vaccine candidates against HIV-1; one based...

Descripción completa

Detalles Bibliográficos
Autores principales: Gómez, Carmen Elena, Perdiguero, Beatriz, Usero, Lorena, Marcos-Villar, Laura, Miralles, Laia, Leal, Lorna, Sorzano, Carlos Óscar S., Sánchez-Corzo, Cristina, Plana, Montserrat, García, Felipe, Esteban, Mariano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8473054/
https://www.ncbi.nlm.nih.gov/pubmed/34579196
http://dx.doi.org/10.3390/vaccines9090959

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8473054/
https://www.ncbi.nlm.nih.gov/pubmed/34579196
http://dx.doi.org/10.3390/vaccines9090959

Ejemplares similares